Burges Salmon has advised Calcivis, a Scottish biotech that aims to revolutionise early-intervention diagnostics in dentistry, on its £5 million investment. The funding was provided by the Scottish National Investment Bank and IFS Maven Equity Finance, which is managed by Maven Capital Partners and is part of the Investment Fund for Scotland, delivered by the British Business Bank. The Burges Salmon team advising Calcivis was led…
Read More…
Source: https://www.scottishlegal.com/articles/burges-salmon-advises-edinburgh-based-biotech-on-investment